François-Joseph-Victor Broussais

Bedeutung für die Hirudotherapie

François-Joseph-Victor Broussais is the figure whose name is most closely associated with the peak era of medical leech use — the so-called leech mania of the 1820s and 1830s, during which French clinical medicine consumed leeches at a scale never seen before or since. The numbers are staggering: France imported and used between thirty and forty million medical leeches in 1833 alone, the majority destined for hospitals in Paris and provincial cities where Broussaisian physiological medicine had become the dominant therapeutic doctrine. Broussais himself was reported to apply fifty or more leeches in a single session for severe gastroenteritis, and his disciples extended the practice to virtually every inflammatory and febrile condition. The theoretical scaffolding for this practice was Broussais's doctrine that nearly all disease originated in localized inflammation of the gastrointestinal mucosa, which secondarily produced systemic symptoms. Therapy therefore aimed at reducing this gastrointestinal inflammation through aggressive local sanguine evacuation — leeches applied to the epigastrium being the preferred intervention because they evacuated blood from the affected territory without the systemic effects of venesection. The doctrine was wrong about pathophysiology but produced enormous quantities of clinical observation that, in retrospect, document the real effects (and harms) of intensive leech application better than any other source in the historical record. Broussais's importance to modern hirudotherapy is double-edged but essential. On one hand, his enthusiasm drove the leech-farming and leech-importing industry to a scale that supported the survival of medical leech expertise through the subsequent nineteenth-century decline; the French Ricarimpex pharmacy, founded in 1845, descends directly from this commercial infrastructure and remains today the world's principal supplier of FDA-cleared medicinal leeches. On the other hand, the abuses of the Broussaisian era — exsanguinated patients, ecologically devastated leech populations — became the cautionary tale that empowered Rudolf Virchow and the cellular-pathology generation to dismiss leech therapy as superstition. ASH treats Broussais as the cautionary patron of the field: the figure whose excesses defined both the apex of leech use and the conditions for its near-extinction.